Marketing Authorization

Get In Touch

The development and marketing of biopharmaceutical products can be a highly complex undertaking. Our holistic yet tailored approach to Global Procedure Management ensures an optimized marketing authorization preparation and submission process designed with the end in mind.


Recognizing the likely involvement of multiple disciplines, work-streams and procedures, potentially spanning multiple regions, our experts can help across all stages of marketing authorization preparation:

  • Pre-submission activities – including seeking early input from the authorities
  • Program or targeted gap analysis
  • Authoring BLA / MAA
  • Dossier evaluation process
  • Publishing and eCTD
  • Support during agency evaluation.


Joined-up thinking, proven success


We have a proven track record of successful applications of a great variety of biopharmaceutical development projects. It helps that we think holistically from the outset – e.g. ensuring that orphan designations, adaptive pathways, PIPS/PSP and any other special considerations are factored in early on.

Our regulatory writing experts have long-standing experience in preparing the relevant documents for submission to the FDA (BLA) and the EMA (MAA) and other authorities worldwide.

We’re known for:

  • Maximizing cost and time efficiencies across regions, with our global thinking
  • Creating a consistent and compelling dossier, through skilled content development and story-boarding by global writing experts
  • Assured regional compliance, thanks to our deep understanding of requirements in all regions


Get In Touch

Insights Hub

Sharing insights, questioning norms, asking the right questions - we'll never lose sight of what you're striving for. Our insight and expertise will help you bring the most innovative therapies within reach of patients around the world.
Placeholder Image

Cell & Gene Therapy: Maximizing Commercialization Potential

How to Navigate the Less Obvious Barriers to Brining Advanced & Highly Targeted Treatments to

Start a conversation today

If you’re developing something truly ground-breaking, Biopharma Excellence is the nearest resource you’ll find to someone who’s been there before.


    We are now Cencora PharmaLex 

    PharmaLex is now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. In 2024 and beyond PharmaLex and all the companies in PharmaLex family will begin a journey to becoming Cencora as well. Cencora brings the companies and services together under one new name. The name will change, but the level of attention and service you receive remains the same.  

    Know more